| Tovorafenib studied in …STUDIED_INderived14 of 14show fewer |
|---|
| → studied in | NCT07441707Phase 1 · active not recruiting A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain Tumours · 14 trials list this drug (7 active) | — | — | Low Grade Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06965114Phase 1/Phase 2 · recruiting Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia · 14 trials list this drug (7 active) | — | — | Hairy Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07206849Phase 2 · not yet recruiting Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG) · 14 trials list this drug (7 active) | — | — | Glioma,Brain Neoplasm,Diffuse Intrinsic Pontine Glioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05566795Phase 3 · active not recruiting DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) · 14 trials list this drug (7 active) | — | — | Low Grade Glioma,Childhood Low Grade Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05465174Phase 2 · recruiting Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults · 14 trials list this drug (7 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03429803Phase 1 · completed DAY101 In Gliomas and Other Tumors · 14 trials list this drug (7 active) | — | — | Low Grade Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985604Phase 2 · terminated Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors · 14 trials list this drug (7 active) | — | — | Solid Neoplasm,Melanoma,Lung Non-Small Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07121829Phase 1 · terminated Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors · 14 trials list this drug (7 active) | — | — | Solid Neoplasm,Melanoma,Malignant Pancreatic Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06381570early Phase 1 · recruiting Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Gliomas · 14 trials list this drug (7 active) | — | — | Low Grade Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04775485Phase 2 · recruiting A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors · 14 trials list this drug (7 active) | — | — | Solid Neoplasm,Low Grade Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05760586approved for marketing Expanded Access Program (EAP) for Tovorafenib (DAY101) in RAF-Altered, Relapsed or Refractory Low-Grade Glioma · 14 trials list this drug (7 active) | — | — | Low Grade Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02723006Phase 1 · terminated Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma · 14 trials list this drug (7 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01425008Phase 1 · completed Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma · 14 trials list this drug (7 active) | — | — | Neoplasm,Solid Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02327169Phase 1 · completed A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic Malignancies · 14 trials list this drug (7 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |